Clinical efficacy and safety of oral ciprofloxacin in pelvic inflammatory disease.
De Wilde
R
R
Department of Obstetrics and Gynecology, Bethesda Clinic (University of Muenster), Wuppertal, Federal Republic of Germany.
D000284:Administration, Oral; D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy*; D012449:Safety; D016896:Treatment Outcome
D000890:Anti-Infective Agents; D002939:Ciprofloxacin